Value of B-type natriuretic peptide in diagnosing left ventricular dysfunction in dialysis-dependent patients

Internal Medicine Journal

Volumn 36, Issue 9, 2006, Pages 552-557

  Zeng, C ^a   Wei, T ^a   Jin, L ^a   Wang, L ^b  

^a LISHUI CENTRAL HOSPITAL   (China)

^b CHARLES STURT UNIVERSITY   (Australia)

Author keywords

B type natriuretic peptide; Chronic renal failure; Haemodialysis; Left ventricular dysfunction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEART LEFT VENTRICLE FAILURE; HEMODIALYSIS PATIENT; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; TIME SERIES ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RENAL DIALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33746818750     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01136.x     Document Type: Article

References (23)

1. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy; evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 1995; 96: 1280-87.
2. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-8.
3. Yoshimura M, Yasue H, Okumura K, Ogawa H, Jougaski M, Mukoyama M et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993; 87: 464-9.
4. Wei CM, Heublein DM, Perrella MA, Lerman A, Rodeheffer RJ, McGregor CG et al. Natriuretic peptide system in human heart failure. Circulation 1993; 88: 1004-1009.
5. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135: 825-32.
6. Yasue H, Obata K, Okumura K, Kurose M, Ogawa H, Matsuyama K et al. Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy. J Clin Invest 1989; 83: 46-51.
7. Maisel A, Krishnaswamy P, Nowak R, McCord J, Hollander JE, Duc P et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-70.
8. Wei TM, Zeng CL, Chen LP, Chen QY, Zhao RY, Lu GX et al. Bedside tests B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients. Eur J Heart Fail 2005; 7: 75-9.
9. Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo F. Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrology 1995; 44: Suppl 1: S61-4.
10. Haug C, Metzele A, Steffgen J, Grunert A. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure. Horm Metab Res 1994; 26: 246-9.
11. Corboy JC, Walker RJ, Simmonds MB, Wilkins GT, Richards AM, Espiner EA. Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in haemodialysis patients. Clin Sci 1994; 87: 679-84.
12. Vesely DL. Natriuretic peptides and acute renal failure. Am J Physiol Renal Physiol 2003; 285: F167-77.
13. Nitta K, Kawashima A, Yumura W, Naruse M, Oba T, Kabaya T et al. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis. Am J Nephrol 1988; 18: 411-15.
14. Nishikimi T, Futoo Y, Tamano K, Takahashi M, Suzuki T, Minami J et al. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease. Am J Kidney Dis 2001; 37: 1201-08.
15. Osajima A, Okazaki M, Tamura M, Anai H, Kabashima N, Suda T et al. Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease. Nephron 2002; 92: 832-9.
16. Naganuma T, Sugimura K, Wada S, Yasumoto R, Sugimura T, Masuda C et al. The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 2002; 22: 437-44.
17. Goto T, Takase H, Toriyama T, Sugiura T, Kurita Y, Tsuru N et al. Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis. Nephron 2002; 92: 610-15.
18. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 2004; 50: 33-50.
19. Fagugli RM, Palumbo B, Ricciardi D, Pasini, Santirosi P, Vecchi L et al. Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron 2003; 95: c60-66.
20. Buckley MG, Sethi D, Markandu ND, Sagnella GA, SingerDR, MacGregor GA. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci 1992; 83: 437-44.
21. Lang CC, Choy A, Henderson I, Coutie W, Struthers AD. Effect of haemodialysis on plasma level of brain natriuretic peptide in patients with chronic renal failure. Clin Sci 1992; 82: 127-31.
22. Haug C, Metzele A, Steffgen J, Kochs M, Hombach V, Grunert A. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. Clin Investig 1994; 72: 430-34.
23. Wahl HG, Graf S, Renz H, Fassbinder W. Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis. Clin Chem 2004; 50: 1071-4.